HAMAMATSU PHARMA RESEARCH, Inc
Have updates for this profile? Please contribute data
= Subscriber Access Only
You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.
With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.
HAMAMATSU PHARMA RESEARCH, Inc - overview
Established
2005
Location
Hamamatsu-shi, Shizuoka, Japan
Primary Industry
Pharmaceuticals
About
Based in Shizuoka, Japan, and founded in 2005 by CEO Takahiro, Hamamatsu Pharma Research Co. , Ltd. is contracted to conduct non-clinical drug efficacy and pharmacology studies to evaluate the effectiveness of drug discovery candidates and support the early stages of drug discovery using original disease models in monkeys. In October 2023, CMIC Holdings Co.
, Ltd. , a portfolio company of Dai Nippon Printing and Taiyo Pacific Partners, will fully acquire Hamamatsu Pharma Research Co. , Ltd. Hamamatsu Pharma Research's product offerings encompass a wide range of therapeutic areas, including the central nervous system, pain management, circulatory system, urinary tract, digestive organs, ophthalmology, and other medical fields.
By focusing on non-human primates, the company employs cynomolgus monkeys, which share anatomical and physiological similarities with humans, to reduce uncertainty and risk in the drug discovery process. The company offers the photochemically-induced thrombosis (PIT) method for creating thrombi in blood vessels using green light and a light-sensitive dye, Rose Bengal. This method has been instrumental in studying clot formation, vascular thickening, sudden hearing loss, myocardial infarction, and other related medical conditions.
Current Investors
CMIC Holdings Co., Ltd.
Primary Industry
Pharmaceuticals
Sub Industries
Pharmaceutical Research & Development
Website
www.hpharma.jp
Company Stage
Add-on
Total Amount Raised
Subscriber access only
HAMAMATSU PHARMA RESEARCH, Inc - deals
| Deals Type | Deal Status | Target (s) | Deal Date | Investor(s) | Seller(s) | Deal size (Mn) | Enterprise value (Mn) | Post-money valuation (Mn) | EBITDA multiple (x) | Revenue multiple (x) | Lead partner (s) |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Add-on | Completed | HAMAMATSU PHARMA RESEARCH, Inc | - |
Displaying 1 - 1 of 1
Time to go Pro
Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.